Pharmaceuticals

Customs duty exemption, GST rate cut to bring down retail prices of cancer drugs

Customs duty exemption, GST rate cut to bring down retail prices of cancer drugs

30 Oct 2024

The maximum retail prices (MRP) of three main drugs used in the treatment of cancer, viz, Trastuzumab, Osimertinib and Durvalumab

Drug regulator finds samples of calcium supplement Shelcal 500 and antacid Pan D as spurious

Drug regulator finds samples of calcium supplement Shelcal 500 and antacid Pan D as spurious

27 Oct 2024

A routine inspection by the Central Drug Regulatory Authority of retail medical shops in select locations of Odisha

Merck pays $30 million upfront to acquire cancer therapy developer Modifi Biosciences

Merck pays $30 million upfront to acquire cancer therapy developer Modifi Biosciences

24 Oct 2024

US pharma multinational Merck has acquired Modifi Biosciences, a developer of new oncology drug molecules, for $30 million upfront and up to $1.3 billion

NPPA hikes ceiling prices of 8 essential drugs by 50%

NPPA hikes ceiling prices of 8 essential drugs by 50%

16 Oct 2024

National Pharmaceutical Pricing Authority (NPPA) has approved a 50 per cent increase in the ceiling prices of 11 scheduled formulations of eight drugs

Novartis India refutes media reports of negotiations with Alkem Labs

Novartis India refutes media reports of negotiations with Alkem Labs

27 Sep 2024

Novartis India, has refuted media reports stating that its parent company is in talks with Mumbai-based Alkem Labs for sale of the Indian arm.

Mankind Pharma to buy Bharat Serums and Vaccines in a Rs13,630-cr deal

Mankind Pharma to buy Bharat Serums and Vaccines in a Rs13,630-cr deal

27 Jul 2024

Mankind Pharma is acquiring Bharat Serums and Vaccines (BVS) from private equity firm Advent International in a deal valued at Rs13,630 crore.

AstraZeneca starts global recall of its controversial Covid 19 vaccine

AstraZeneca starts global recall of its controversial Covid 19 vaccine

08 May 2024

Days after admitting that its Covid 19 vaccine could cause blood clot in some people, British-Swedish pharmaceutical company AstraZeneca

Novartis to acquire US-based Mariana Oncology in $1.75 bn deal

Novartis to acquire US-based Mariana Oncology in $1.75 bn deal

03 May 2024

Swiss drug maker Novartis has agreed to acquire US-based Mariana Oncology in a deal worth $1.75 billion, as the company seeks advance the development of precision treatment for cancer.

Chinese industrial goods accounted for 30% of India’s 2023-24 imports: GTRI report

Chinese industrial goods accounted for 30% of India’s 2023-24 imports: GTRI report

29 Apr 2024

China's share in India's industrial goods imports jumped to 30 per cent in 2023-24 from 21 per cent over the 15-year period between 2008-09 and 2023-24, as per a report published by Global Trade Research Initiative (GTRI).

Govt revamps technology upgradation scheme for pharma sector

Govt revamps technology upgradation scheme for pharma sector

13 Mar 2024

The union government on Monday announced a revamped scheme of assistance for technology upgradation in the pharmaceuticals sector – a move aimed at ensuring that Indian industries are on par with global standards.

Novartis announces strategic review of its India business

Novartis announces strategic review of its India business

19 Feb 2024

Swiss pharma multinational Novartis AG has started a strategic review of its Indian arm, possibly with the intent of selling it off.

Taro to merge with Sun Pharma in $350 million deal

Taro to merge with Sun Pharma in $350 million deal

21 Jan 2024

Sun Pharmaceutical Industries Limited and Israel-based Taro Pharmaceutical Industries Ltd have entered into a definitive merger agreement under which Sun Pharma

LyondellBasell to acquire 35% of Saudi petrochemical company for $500 m

LyondellBasell to acquire 35% of Saudi petrochemical company for $500 m

17 Jan 2024

LyondellBasell, a global leader in petrochemicals, today announced the signing of an agreement to acquire a 35 per cent interest in Saudi Arabia–based National Petrochemical Industrial Company (NATPET)

Bristol Myers Squibb to acquire RayzeBio for $4.1 billion in cash

Bristol Myers Squibb to acquire RayzeBio for $4.1 billion in cash

31 Dec 2023

American multinational pharmaceutical company Bristol Myers Squibb on Tuesday said it would buy RayzeBio for about $4.1 billion to bolster its cancer drug business

AstraZeneca to buy China's Gracell Biotechnologies for $1.2 bn

AstraZeneca to buy China's Gracell Biotechnologies for $1.2 bn

27 Dec 2023

Anglo-Swedish multinational pharmaceutical and biotechnology company AstraZeneca has agreed to acquire China-based Gracell Biotechnologies Inc, for about $1.2 billion.

Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 bn

Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 bn

26 Dec 2023

Bristol Myers Squibb on Friday agreed to acquire Karuna Therapeutics, a pioneer in schizophrenia drugs, for $330 per share in cash

Pfizer is set to acquire Seagen for $43 billion and create a new oncology division

Pfizer is set to acquire Seagen for $43 billion and create a new oncology division

13 Dec 2023

In a significant move, Pfizer has announced its anticipation of concluding the $43 billion deal to acquire cancer drug maker Seagen by 16 December 2023.

Western drugmakers pivot to India as tensions with China prompt supply chain shifts

Western drugmakers pivot to India as tensions with China prompt supply chain shifts

27 Nov 2023

In a strategic move to reduce dependence on Chinese contractors in drug production, global pharmaceutical companies are turning to Indian manufacturers.

Johnson & Johnson proposes to pay nearly $9 bn to settle lawsuits in US

10 Apr 2023

SCO showcases first international conference and expo on traditional medicine

09 Mar 2023

AstraZeneca to acquire CinCor Pharma in a deal worth $1,8 bn

11 Jan 2023

Eli Lilly to buy gene therapy company Akouos for $487 million

27 Oct 2022

Hetero acquires Johnson & Johnson’s Telangana plant

26 Oct 2022

Torrent Pharma to acquire Curatio Health for Rs2,000 cr

03 Oct 2022

Moderna sues Pfizer-BioNtech for patent violation

02 Sep 2022

According to Moderna, Pfizer-BioNTech copied mRNA technology that Moderna had patented between 2010 and 2016, well before Covid-19 emerged in 2019

View details about the software product Informachine News Trackers